FEMA Nuclear Disaster Planning Addendum

Infection-Associated Chronic Conditions and Population Vulnerability in Radiological Emergencies

By Cynthia Adinig

This paper is part of the CYNAERA FEMA Addendum Series examining how modern population health trends interact with disaster preparedness systems. Earlier analyses in this series evaluated wildfire smoke exposure and flood-related environmental destabilization. The present paper examines nuclear and radiological emergency planning through the same lens: how the expanding population living with infection-associated chronic conditions may alter vulnerability during large-scale disasters.

CYNAERA research integrates public health data, environmental risk analysis, and population modeling to evaluate how chronic illness intersects with infrastructure and emergency response systems. This approach draws from epidemiology, disaster medicine, environmental health, and sociotechnical systems research to identify planning gaps that may emerge as population health patterns evolve.

Introduction

Nuclear disaster planning has traditionally focused on blast effects, radiation exposure, contamination pathways, evacuation timing, and sheltering protocols. These priorities remain essential. However, disaster frameworks are also built on assumptions about the physiological resilience of the population they serve.

Over the past five years, the health landscape of the United States has changed in ways that may influence how populations respond to environmental crises. The COVID-19 pandemic produced a large and persistent cohort of individuals living with Long COVID, while also increasing recognition of a broader family of infection-associated chronic conditions including myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), dysautonomia, mast cell activation disorders, connective tissue disorders, and other multisystem illnesses (Davis et al., 2021; Al-Aly et al., 2022; Komaroff & Lipkin, 2023; NASEM, 2024).

These conditions are relevant to disaster preparedness because they often involve altered tolerance to physiological stress. Research across autonomic disorders, chronic inflammatory conditions, and post-viral illness has documented disruptions in cardiovascular regulation, immune signaling, neurological processing, and energy metabolism (Raj et al., 2021; Phetsouphanh et al., 2022; Peluso et al., 2023; Vernon et al., 2022). Such changes can influence how individuals respond to environmental exposures including smoke, heat, particulate pollution, chemical irritants, dehydration, and prolonged physical stress.

At the population level, the scale of this shift is significant. Earlier CYNAERA planning estimates used a conservative adult Long COVID prevalence range of approximately 35–50 million Americans. Subsequent prevalence research and continued case accumulation now support a higher working baseline near 65 million adults who have experienced Long COVID. When overlapping infection-associated chronic conditions are considered, the total population living with at least one such illness may plausibly reach between 75 and 90 million Americans.

Importantly, this population is not static. Modeling presented in One New Case Every Minute: The Unfinished Long COVID Emergency in the United States suggests the country may still be adding thousands of new Long COVID cases daily. Because these illnesses accumulate over time rather than resolving quickly for many patients, the medically vulnerable population relevant to disaster planning continues to expand each year. This paper explores what those changes may mean for nuclear disaster preparedness. It examines whether current planning frameworks adequately reflect the physiological realities of a population increasingly affected by chronic neuroimmune illness.

The Expanding Burden of Infection-Associated Chronic Conditions

Post-infectious chronic illness has been documented for more than a century, following outbreaks of influenza, Epstein–Barr virus, enteroviruses, and other pathogens. Conditions such as ME/CFS have long been associated with viral onset, while autonomic nervous system disorders such as postural orthostatic tachycardia syndrome (POTS) have been linked to immune and neurological disturbances following infection (Komaroff & Bateman, 2021; Raj et al., 2021).

The COVID-19 pandemic dramatically increased the scale and visibility of this phenomenon. Long COVID is now widely recognized as a heterogeneous condition involving persistent symptoms across multiple organ systems, including fatigue, cognitive impairment, cardiovascular abnormalities, respiratory symptoms, and autonomic dysfunction (Davis et al., 2021; Sudre et al., 2021). Large population studies using electronic health records have documented increased risks of neurological disorders, cardiovascular disease, and metabolic complications following SARS-CoV-2 infection (Al-Aly et al., 2022).

Beyond Long COVID itself, research has highlighted strong overlap between post-COVID illness and previously recognized neuroimmune conditions. Immunological studies suggest that persistent viral reservoirs, autoimmune responses, endothelial damage, and chronic inflammatory signaling may contribute to long-term symptoms (Iwasaki et al., 2023; Peluso et al., 2023). Similar mechanisms have been proposed in ME/CFS and other post-viral illnesses (Komaroff & Lipkin, 2023). This convergence suggests that the pandemic did not simply create a new disease category. It expanded a broader class of infection-associated chronic conditions that had previously been underrecognized within healthcare systems.

Population-Scale Implications for Emergency Planning

Estimating the prevalence of infection-associated chronic conditions is challenging because many patients remain undiagnosed or misclassified. Surveillance systems often capture only individuals with formal diagnoses, while many patients with overlapping symptoms receive fragmented care across multiple specialties.

Even conservative estimates indicate a major shift in the U.S. health landscape. Updated modeling informed by the U.S. Chronic Condition Undercount Correction (US-CCUC™) framework supports a planning estimate of roughly 65 million adults who have experienced Long COVID. When additional conditions such as ME/CFS, dysautonomia, mast cell activation disorders, fibromyalgia, and connective tissue disorders are considered, the number of Americans living with at least one infection-associated chronic condition may plausibly range between 75 and 90 million individuals.

This scale matters for disaster planning because it changes the baseline assumptions about population resilience. Emergency management literature has increasingly emphasized that vulnerability during disasters is shaped not only by infrastructure damage but also by underlying health conditions and social determinants (Peek et al., 2018; Aldrich & Meyer, 2015). Chronic illness can influence evacuation capacity, medication dependence, exposure sensitivity, and recovery trajectories following disasters.

Public health research following Hurricane Katrina, the Fukushima nuclear disaster, and other major events has shown that individuals with chronic health conditions often experience disproportionate impacts during crises due to disrupted medical care, environmental exposures, and infrastructure breakdowns (Adams et al., 2011; Nomura et al., 2016; Kishore et al., 2018). Understanding the size and characteristics of medically vulnerable populations is therefore essential for accurate disaster preparedness planning.

Physiological Characteristics That Increase Disaster Vulnerability

Although infection-associated chronic conditions encompass multiple diagnoses, many share physiological patterns that influence how individuals respond to environmental stress. These patterns are particularly relevant during disasters where people may encounter poor air quality, extreme temperatures, contaminated environments, or disrupted access to care. Research across Long COVID, ME/CFS, dysautonomia, and related conditions has identified several recurring biological features that may influence disaster vulnerability.

Common physiological characteristics include:

• autonomic nervous system instability affecting heart rate, blood pressure, and thermoregulation (Raj et al., 2021; Vernino et al., 2021)

• immune dysregulation and chronic inflammatory signaling following viral infection (Phetsouphanh et al., 2022; Peluso et al., 2023)

• mitochondrial and metabolic dysfunction affecting energy production and recovery (Naviaux et al., 2016; Komaroff & Lipkin, 2023)

• heightened sensitivity to environmental triggers such as particulate pollution, allergens, or chemical irritants (Lipkin et al., 2023; CDC Environmental Health reports)

• neurological symptoms including cognitive dysfunction, sensory sensitivity, and fatigue (Taquet et al., 2022; NASEM, 2024)

These biological features suggest that disaster exposure is not only an external environmental event for individuals with infection-associated chronic illness. It is often an interaction between environmental stress and an already destabilized physiological system. Recognizing these interactions is an important step toward evaluating whether existing nuclear disaster preparedness frameworks fully account for the evolving health profile of the U.S. population.

Environmental Destabilization and Chronic Illness

Environmental destabilization refers to sudden or sustained environmental conditions that place physiological stress on human populations. Disaster research has long recognized that hazards rarely act in isolation. Outcomes are shaped by the interaction between environmental exposure and the health status of the population experiencing that exposure. Scholars in disaster medicine and environmental health have repeatedly emphasized that the same hazard can produce very different outcomes depending on underlying vulnerability, access to resources, and baseline population health. In this sense, disasters are not only physical events but systems events that test the resilience of biological, social, and infrastructural systems simultaneously.

Environmental health research increasingly demonstrates that individuals living with chronic illness respond differently to environmental stress signals than otherwise healthy populations. Studies examining air pollution, extreme heat, and wildfire smoke consistently show that medically vulnerable individuals experience higher morbidity even when environmental conditions fall below regulatory safety thresholds. These findings reinforce a central principle in disaster preparedness: population vulnerability is dynamic and must be considered when evaluating environmental risk.

Infection-associated chronic conditions introduce a new dimension to this dynamic.

Individuals living with Long COVID, ME/CFS, dysautonomia, and mast cell activation disorders often experience chronic neuroinflammation, mitochondrial dysfunction, autonomic instability, and immune hypersensitivity. These biological traits alter how the body responds to environmental signals including radiation exposure, particulate pollution, carbon monoxide, and heat stress. When multiple environmental stressors occur simultaneously, as they often do during disaster environments, the cumulative physiological burden can exceed the tolerance thresholds of individuals managing chronic neuroimmune illness.

CYNAERA terrain modeling evaluates these interactions by examining how layered environmental exposures interact with chronic illness physiology. Rather than assessing hazards individually, the model integrates multiple environmental signals to estimate when combined stressors may trigger physiological destabilization. The resulting thresholds highlight how individuals with infection-associated chronic conditions may experience symptom escalation at exposure levels below federal safety benchmarks designed for healthy populations.

Table 4: Environmental Sensitivity and Terrain Risk Mapping for IACC Patients

Environmental Agent	Federal Safety Benchmark	IACC Terrain Risk Threshold	Flare Effects Observed	IACC Multiplier
Radiation	<10 R/h	≥1.0 R/h	Autonomic crash, hypoxia, seizure risk	×2.5–3.0
Carbon Monoxide	<70 ppm	5–15 ppm	Neuroinflammation, chest tightness	×2.0
PM2.5 (Air Quality)	AQI <50	AQI ≥30	Fatigue, MCAS flare, cognitive dysfunction	×2.3
Heat Index	<80°F	≥75°F indoors	Dysautonomia spike, dehydration risk	×1.5
Emotional Shock / Stress	Moderate resilience	Immediate trigger	Neuroflare, MCAS shock	×2.0

These modeled thresholds illustrate how disaster environments can amplify physiological stress in vulnerable populations. While radiation exposure remains the central hazard during nuclear emergencies, combined environmental signals such as heat, particulate pollution, and toxic gases may significantly increase medical risk among individuals already experiencing immune and autonomic dysregulation.

Lessons from the FEMA Addendum Series: Wildfire and Flood

The CYNAERA FEMA Addendum Series was developed to examine how evolving health and environmental conditions intersect with existing disaster preparedness frameworks. Earlier papers in the series focused on wildfire smoke exposure and flood-related environmental destabilization, two hazards that have increased in frequency and severity due to climate change and land-use patterns. Although those analyses examined different environmental hazards, they produced a similar conclusion: many disaster planning systems were built around assumptions that no longer fully match present-day conditions.

The wildfire analysis examined how particulate pollution from large-scale fires interacts with respiratory illness, cardiovascular disease, and neuroimmune conditions. Research has consistently shown that wildfire smoke contains a complex mixture of fine particulate matter, volatile organic compounds, and combustion byproducts that can penetrate deeply into the lungs and bloodstream (Reid et al., 2016; Cascio, 2018). These exposures have been associated with increased hospitalizations for respiratory and cardiovascular illness during wildfire events. Importantly, individuals with preexisting health conditions appear to experience greater morbidity and longer recovery periods following smoke exposure. For patients with chronic neuroimmune illnesses such as ME/CFS and Long COVID, smoke exposure may also trigger systemic symptom worsening, including fatigue, neurological dysfunction, and autonomic instability. The wildfire addendum therefore emphasized the need for improved air filtration access, public communication strategies, and shelter planning that accounts for populations with heightened sensitivity to particulate pollution.

The flood preparedness analysis highlighted a different set of environmental stressors but revealed similar structural vulnerabilities. Flood events can expose communities to mold growth, contaminated water, chemical runoff, and prolonged displacement from homes and medical infrastructure. Studies following major flooding events have documented increased rates of respiratory illness, mental health disorders, and infectious disease outbreaks among affected populations (Alderman et al., 2012; Du et al., 2010). Mold exposure in particular has been associated with respiratory symptoms and immune responses in susceptible individuals. For patients with mast cell activation disorders or severe environmental sensitivities, prolonged exposure to damp or mold-contaminated environments may lead to significant symptom escalation and difficulty accessing safe housing during recovery periods.

Together, these earlier analyses revealed a consistent pattern. Disaster environments often introduce environmental stressors that interact with underlying chronic illness in ways that amplify health risks. These interactions do not necessarily require catastrophic exposures. Even moderate environmental changes, such as sustained particulate pollution, poor indoor air quality, chemical exposure, or disrupted access to medications, can destabilize vulnerable individuals. The implications for preparedness planning are significant. Systems designed primarily around structural damage and acute trauma may overlook the cumulative effects of environmental stress on populations already managing chronic illness.

The nuclear addendum builds on this framework by examining how similar dynamics might apply during radiological emergencies. While nuclear disasters involve unique hazards related to radiation exposure and contamination, they also generate many of the same environmental stressors examined in the wildfire and flood analyses. Evacuations, crowded shelters, infrastructure disruption, contaminated environments, and prolonged displacement are all common features of nuclear emergencies. Understanding how these conditions intersect with the physiology of infection-associated chronic illness is therefore an important step in evaluating whether existing preparedness frameworks remain adequate.

Environmental Conditions During Nuclear & Radiological Emergencies

Nuclear disasters introduce a complex combination of environmental hazards that extend beyond radiation exposure alone. Historical events such as the Chernobyl accident and the Fukushima Daiichi disaster demonstrated that radiological emergencies often involve cascading environmental and social disruptions. These disruptions include large-scale evacuation, prolonged displacement, infrastructure damage, contaminated air and water systems, psychological stress, and interruptions in healthcare access. For many affected populations, the long-term consequences of these disasters were shaped as much by environmental instability and displacement as by radiation exposure itself.

Radiological emergency guidance emphasizes rapid sheltering to reduce exposure during the early stages of fallout. This strategy remains one of the most effective protective actions for reducing radiation dose. However, shelter environments themselves can introduce environmental conditions that affect vulnerable populations differently. Crowded shelters may involve poor ventilation, elevated indoor temperatures, chemical disinfectants, noise exposure, and limited medical support. For individuals living with infection-associated chronic conditions, these environmental factors can trigger autonomic instability, respiratory distress, neurological symptoms, or mast cell activation.

Evacuation conditions may also create physiological challenges. Disaster evacuations often require individuals to travel long distances, stand in lines, or endure extended transportation delays. Individuals with dysautonomia or post-exertional symptom worsening may experience rapid symptom escalation under these conditions, including fainting, tachycardia, or severe fatigue. Studies examining evacuations following the Fukushima disaster found that medically vulnerable populations experienced significant health deterioration during relocation processes, largely due to disrupted medical care and environmental stress.

CYNAERA modeling adjusts traditional nuclear disaster zones to account for these physiological vulnerabilities. By integrating environmental sensitivity data with FEMA zone classifications, the model produces revised survivability estimates that reflect how chronic illness may alter risk patterns across disaster zones.

Table 5: IACC-Adjusted Shelter Risk Zones

FEMA Zone	Healthy Survivor Risk	IACC Survivor Risk	Challenges for IACC Patients
Severe Damage Zone (0–3 mi)	95%+ fatality	~99.9% fatality	Unsurvivable environment
Moderate Damage Zone (3–10 mi)	55–65% survival	<20% survival	Power loss, radiation flares
Light Damage Zone (10–20 mi)	Most survive	40–60% collapse	Air quality degradation, exertion stress
Fallout / Hot Zone (20–50 mi)	Mild exposure	10–25% flare risk	MCAS and dysautonomia flares

These adjusted estimates suggest that survivability patterns may differ significantly for individuals with chronic neuroimmune illness. Improving shelter conditions, particularly ventilation and filtration, may therefore represent a critical strategy for reducing disaster mortality among medically vulnerable populations.

FEMA Nuclear Preparedness Assumptions & Population Health

Nuclear and radiological emergency preparedness in the United States is largely guided by frameworks developed through the Federal Emergency Management Agency (FEMA), the Nuclear Regulatory Commission (NRC), the Environmental Protection Agency (EPA), and international radiation protection organizations. These frameworks emphasize rapid protective actions such as sheltering in place, evacuation from high-exposure zones, contamination control, and access to emergency medical care (FEMA, 2019; NRC, 2023; EPA, 2022). These approaches are grounded in decades of research on radiation exposure thresholds and population-level protective actions designed to minimize acute harm. The underlying planning logic assumes that if populations can reduce exposure, reach shelter, and access medical support within defined time windows, the majority of individuals will tolerate the immediate environmental stress long enough for stabilization and recovery.

That assumption historically reflected a population where chronic illness existed but did not dominate the national health profile to the extent it does today. Disaster medicine literature has long acknowledged medically vulnerable groups, including the elderly, individuals with disabilities, and patients dependent on specialized medical equipment (HHS ASPR, 2017; Peek et al., 2018). However, these categories typically focus on individuals with visible functional limitations or clear medical dependencies. Infection-associated chronic conditions challenge that framework because they often exist in a large population that may appear outwardly functional while still experiencing significant physiological instability under stress.

Emergency preparedness guidance frequently relies on generalized concepts of population resilience, assuming that most adults can withstand short-term environmental strain if basic needs such as shelter, hydration, and medical triage are available. Yet research on chronic neuroimmune conditions suggests that the threshold for physiological destabilization can vary widely among individuals depending on autonomic regulation, immune function, and metabolic resilience (Raj et al., 2021; Komaroff & Lipkin, 2023; Iwasaki et al., 2023). In practical terms, a shelter environment that is technically safe from a radiation exposure standpoint may still present significant physiological challenges for individuals whose autonomic systems struggle to regulate heart rate, blood pressure, or temperature in crowded or stressful environments.

This distinction becomes increasingly relevant as the population living with infection-associated chronic conditions grows. When tens of millions of Americans experience some degree of autonomic dysfunction, immune dysregulation, or environmental sensitivity, the category of medically vulnerable individuals expands far beyond traditional disaster planning assumptions. Emergency frameworks that were originally designed for a relatively healthy population must therefore consider whether the baseline resilience of that population has shifted. The goal is not to rewrite radiation safety protocols or evacuation doctrine. Instead, it is to recognize that the physiological diversity of the modern population may influence how individuals respond to the environmental conditions created by nuclear emergencies.

Potential Preparedness Gaps for Chronic Condition Populations

When examining nuclear disaster preparedness through the lens of infection-associated chronic illness, several potential gaps begin to emerge. These gaps do not necessarily reflect failures in emergency management systems, but rather the reality that many preparedness frameworks were developed before the large-scale emergence of Long COVID and related conditions. As public health landscapes evolve, preparedness strategies must occasionally be revisited to ensure they remain aligned with population needs.

One area of concern involves shelter environments. Emergency shelters are designed to protect populations from immediate hazards such as radiation exposure or extreme weather. However, these environments often involve crowded conditions, artificial lighting, limited ventilation, noise, and exposure to cleaning chemicals or disinfectants. For individuals with mast cell activation disorders, dysautonomia, or neurological hypersensitivity, these environmental factors can trigger significant physiological responses. Research on environmental health and chronic illness suggests that individuals with heightened immune or autonomic sensitivity may experience symptom escalation when exposed to irritants, pollutants, or sensory stressors (Lipkin et al., 2023; Frumkin et al., 2020).

Another potential gap involves evacuation logistics. Evacuation strategies frequently require individuals to travel long distances, stand in lines, or navigate transportation disruptions. For people with dysautonomia or post-exertional symptom exacerbation, these conditions can lead to rapid physiological deterioration, including fainting, tachycardia, or severe fatigue. Disaster medicine studies following major evacuations have documented increased mortality among medically fragile populations when evacuation processes are poorly adapted to health needs (Nomura et al., 2016; Murakami et al., 2017). Although these studies primarily examined elderly populations, the underlying lesson applies broadly: evacuation planning must account for individuals whose physiological tolerance for exertion is limited.

Medical triage during disasters may also present challenges when chronic neuroimmune illness is involved. Symptoms such as tachycardia, dizziness, shortness of breath, or cognitive confusion may be interpreted as anxiety or psychological distress during chaotic emergency situations. However, these symptoms can also reflect autonomic dysfunction or other physiological processes associated with infection-associated chronic conditions. Without awareness of these conditions, responders may overlook underlying medical instability or misinterpret symptom patterns during triage assessments.

A final gap involves recovery and long-term displacement. Nuclear disasters often lead to prolonged relocation of affected populations, sometimes lasting months or years. During this period, individuals may lose access to established healthcare providers, medications, and environmental conditions that help stabilize chronic illness. Studies examining displacement after disasters have consistently shown that interruptions in medical care contribute to worsening outcomes among individuals with chronic diseases (Adams et al., 2011; Kishore et al., 2018). For patients managing complex neuroimmune conditions, maintaining continuity of care may be particularly important for preventing severe health deterioration.

Taken together, these potential gaps highlight the importance of integrating modern population health data into disaster preparedness planning. As infection-associated chronic conditions become more widely recognized and better understood, emergency management systems may benefit from considering how these illnesses interact with disaster environments.

Shelter Readiness and Infrastructure Vulnerability

Shelter infrastructure plays a critical role in disaster survivability, particularly during nuclear emergencies where indoor protection significantly reduces radiation exposure. FEMA guidance relies heavily on sheltering strategies during the initial fallout period, emphasizing buildings that provide effective radiation shielding and structural protection. However, radiation shielding alone does not fully determine whether a shelter environment remains physiologically safe for all occupants.

For individuals with infection-associated chronic illness, indoor environmental conditions can strongly influence health stability. Buildings with poor ventilation, aging HVAC systems, or unstable electrical infrastructure may produce environments that trigger symptom escalation in individuals sensitive to particulate pollution, chemical exposure, or temperature fluctuations. These vulnerabilities are particularly relevant in regions with older building stock, mobile housing concentrations, or limited access to modern air filtration systems.

The CYNAERA Shelter Conversion Score (SCS™) was developed to evaluate how well regional infrastructure can support medically vulnerable populations during disaster conditions. The model integrates several factors including population density, chronic illness prevalence, housing quality, HVAC infrastructure, and electrical grid reliability. Higher scores indicate regions where shelter infrastructure may be insufficient to support individuals with heightened environmental sensitivity during emergency events.

Table 6: Regional Risk Assessment for IACC-Safe Shelters

County / Region	SCS™ Score	Dominant Risks	% IACC Affected	Key Barriers
Hidalgo County, TX	87	Mobile housing, HVAC loss	21%	Extreme heat, radiation exposure risks
East Baton Rouge Parish, LA	74	High MCAS prevalence, weak sheltering	19%	AQI shifts, chemical exposure
Navajo Nation, AZ/NM	82	Substandard buildings, no HEPA filtration	23%	Limited power, no air scrubbers

These findings highlight important geographic disparities in disaster preparedness. Rural regions often face infrastructure limitations that restrict access to advanced shelter systems, while urban areas may struggle with overcrowding and aging building stock. Addressing these vulnerabilities may require targeted investment in shelter upgrades, particularly ventilation and air filtration systems capable of supporting sensitive populations.

Economic Readiness and Disaster Response Financing

Disaster response in the United States relies heavily on local and state governments during the earliest stages of an emergency. Although federal assistance can provide substantial resources, the first seventy-two hours of disaster response typically depend on municipal budgets and regional emergency reserves. During this period, local jurisdictions must fund evacuation logistics, emergency medical response, shelter operations, and infrastructure stabilization before federal funding mechanisms fully activate.

The growing prevalence of infection-associated chronic illness introduces additional financial considerations into this early response window. Individuals managing conditions such as Long COVID, ME/CFS, dysautonomia, and mast cell activation disorders may require stabilization measures including hydration support, oxygen access, antihistamines, air filtration environments, and specialized medical monitoring. While these interventions are relatively inexpensive on a per-patient basis, their cumulative cost becomes significant when large populations require assistance simultaneously.

The CYNAERA Economic Risk Readiness Index (ERRI™) evaluates how prepared jurisdictions are to absorb these costs during the early stages of disaster response. The model incorporates variables including chronic illness prevalence, emergency health system capacity, municipal fiscal flexibility, and projected healthcare demand during disaster scenarios.

Table 7: County-Level ERRI Assessment

County	ERRI Score	Key Risks	Recommended Funding Increase
Harris County, TX	3.96	High IACC prevalence, budget constraints	+20% for shelters and stabilization resources
Bronx County, NY	5.12	Low health capacity, dense population	+30% for mobile health units and HEPA filtration
Maricopa County, AZ	2.47	Moderate IACC prevalence, infrastructure strain	+15% for HVAC upgrades and stabilization kits

ERRI™ estimates suggest that jurisdictions with higher chronic illness prevalence may require additional emergency preparedness funding to maintain adequate response capacity. Investments in shelter upgrades, medical stabilization kits, and ventilation infrastructure could reduce both mortality risk and long-term healthcare costs during disaster recovery.

Integrating economic readiness assessments into preparedness planning may therefore strengthen both humanitarian outcomes and fiscal resilience as the prevalence of infection-associated chronic illness continues to grow across the United States.

Research Gaps and Data Needs

Although awareness of infection-associated chronic conditions has grown substantially since the beginning of the COVID-19 pandemic, many aspects of these illnesses remain under investigation. This uncertainty presents both a challenge and an opportunity for disaster preparedness research. Understanding how chronic neuroimmune illness interacts with environmental stressors during disasters will require interdisciplinary collaboration across public health, environmental science, emergency management, and clinical medicine.

One key research need involves improved prevalence estimates. Surveillance systems for conditions such as Long COVID, ME/CFS, dysautonomia, and mast cell activation disorders are still evolving, and many patients remain undiagnosed or misclassified within healthcare systems. Population-level modeling approaches such as CYNAERA’s U.S. Chronic Condition Undercount Correction framework attempt to address this gap by adjusting for diagnostic undercapture and surveillance limitations. Continued research using multiple data sources, including electronic health records, population surveys, and longitudinal cohort studies, will help refine these estimates and provide clearer insights into the scale of the affected population.

Another area requiring further study is the interaction between environmental exposures and chronic neuroimmune illness. Environmental health research has already documented the effects of air pollution, heat stress, and chemical exposure on populations with respiratory or cardiovascular disease (Brook et al., 2010; Cascio, 2018). However, less is known about how these exposures affect individuals with conditions characterized by autonomic dysfunction, immune dysregulation, or mitochondrial impairment. Investigating how environmental stressors influence symptom trajectories in these populations could help emergency planners better anticipate health needs during disasters.

Disaster response data also represent an important research frontier. Historical analyses of events such as Hurricane Katrina, Fukushima, and major wildfire disasters have shown that chronic illness can significantly influence recovery outcomes and healthcare utilization after disasters (Adams et al., 2011; Nomura et al., 2016; Kishore et al., 2018). Future research could examine whether similar patterns occur among individuals living with infection-associated chronic conditions, particularly during evacuations, sheltering periods, or prolonged displacement.

Finally, integrating chronic illness considerations into disaster preparedness planning may require new forms of collaboration between public health researchers and emergency management agencies. Emergency planning models have traditionally focused on infrastructure resilience, hazard mitigation, and rapid response systems. Expanding these models to incorporate population health dynamics could provide a more comprehensive understanding of disaster risk and recovery potential.

Environmental Trigger Synthesis

Environmental exposures associated with symptom worsening in ME/CFS frequently share common biological pathways. Mold contamination in damp indoor environments can release spores, fragments, and microbial compounds that stimulate immune signaling and respiratory irritation (Institute of Medicine, 2004; Mendell et al., 2011). Air pollution exposures including particulate matter, nitrogen dioxide, ozone, sulfur dioxide, and polycyclic aromatic hydrocarbons are known to increase oxidative stress, inflammatory cytokine signaling, and autonomic strain (Pope et al., 2016; Gawda et al., 2018; Ciencewicki & Jaspers, 2007; Jerrett et al., 2009). Volatile organic compounds from indoor materials and urban emissions can further contribute to neuroinflammatory and mast cell–related responses in susceptible individuals (ATSDR, 2020; Hanna et al., 2021).

Together these environmental stressors may function as flare amplifiers in people living with infection-associated chronic conditions. Rather than acting as primary causes of disease, they interact with existing immune dysregulation, autonomic instability, and mitochondrial dysfunction to increase the probability of symptom destabilization.

Conclusion

The purpose of this paper is not to suggest that nuclear disaster preparedness systems are fundamentally flawed or incapable of protecting the public. FEMA, the Nuclear Regulatory Commission, the Environmental Protection Agency, and other agencies have spent decades developing sophisticated frameworks designed to minimize radiation exposure and coordinate emergency response. These systems remain critical for protecting communities in the event of radiological emergencies.

However, disaster planning must continually adapt to changes in the environments and populations it serves. Over the past several years the United States has experienced a significant shift in population health driven by the expansion of infection-associated chronic conditions, particularly Long COVID. Updated prevalence estimates suggest that tens of millions of Americans now live with conditions involving autonomic instability, immune dysregulation, and reduced tolerance to environmental stress. When disasters occur, these physiological characteristics may interact with environmental conditions in ways that increase vulnerability for a substantial portion of the population.

The findings presented in this analysis suggest that nuclear disaster preparedness planning may benefit from incorporating modern population health realities into existing frameworks. Doing so does not require abandoning established radiation safety principles. Instead, it involves recognizing that the baseline assumptions about physiological resilience may no longer fully reflect the health profile of the U.S. population.

Key considerations emerging from this analysis include:

• infection-associated chronic conditions now affect a large and growing share of the U.S. population 

• environmental destabilization during disasters can interact with chronic illness to amplify health risks 

• shelter conditions, evacuation logistics, and medical triage systems may require adjustments to accommodate individuals with invisible chronic illness 

• incorporating population health data into preparedness planning may improve both humanitarian outcomes and long-term economic resilience

Disaster preparedness has always evolved alongside advances in science and changes in society. Recognizing the implications of infection-associated chronic illness represents the next step in that ongoing process. As the understanding of Long COVID and related conditions continues to expand, integrating that knowledge into emergency management planning may help strengthen the resilience of communities facing future environmental and radiological hazards.

CYNAERA Frameworks Referenced in This Paper 

This paper draws on a defined subset of CYNAERA white papers that establish the theoretical, methodological, and operational foundations for Minimum Viable Data, nuance aware LLMs. The references below are deeper insights on the models, definitions, and outcomes presented here.

• The Pathophysiology of Infection-Associated Chronic Conditions

• Bioadaptive Systems Therapeutics™ (BST): Engineering Remission Through Terrain Logic

• National Prevalence Estimates for Infection-Associated Chronic Conditions (IACCs)

• CYNAERA’s VitalGuard™ Environmental Flare Risk Engine

• The Forgotten Pandemic Threat: Climate-Driven Fungal Emergence

• The Hidden Public Health Cost of AI Data Centers

• Aligned Intelligence Method (AIM™)

• The Moral Adinig Method™: A Framework for Harm-Aware AI Learning

Author’s Note:

All insights, frameworks, and recommendations in this written material reflect the author's independent analysis and synthesis. References to researchers, clinicians, and advocacy organizations acknowledge their contributions to the field but do not imply endorsement of the specific frameworks, conclusions, or policy models proposed herein. This information is not medical guidance.

Patent-Pending Systems

​Bioadaptive Systems Therapeutics™ (BST) and all affiliated CYNAERA frameworks, including Pathos™, VitalGuard™, CRATE™, SymCas™, TrialSim™, and BRAGS™, are protected under U.S. Provisional Patent Application No. 63/909,951.

Licensing and Integration

CYNAERA partners with universities, research teams, federal agencies, health systems, technology companies, and philanthropic organizations. Partners can license individual modules, full suites, or enterprise architecture. Integration pathways include research co-development, diagnostic modernization projects, climate-linked health forecasting, and trial stabilization for complex cohorts. You can get basic licensing here at CYNAERA Market.

Support structures are available for partners who want hands-on implementation, long-term maintenance, or limited-scope pilot programs.

About the Author 

Cynthia Adinig is a researcher, health policy advisor, author, and patient advocate. She is the founder of CYNAERA and creator of the patent-pending Bioadaptive Systems Therapeutics (BST)™ platform. She serves as a PCORI Merit Reviewer, Board Member at Solve M.E., and collaborator with Selin Lab for t cell research at the University of Massachusetts.

Cynthia has co-authored research with Harlan Krumholz, MD, Dr. Akiko Iwasaki, and Dr. David Putrino, though Yale’s LISTEN Study, advised Amy Proal, PhD’s research group at Mount Sinai through its patient advisory board, and worked with Dr. Peter Rowe of Johns Hopkins on national education and outreach focused on post-viral and autonomic illness. She has also authored a Milken Institute essay on AI and healthcare, testified before Congress, and worked with congressional offices on multiple legislative initiatives. Cynthia has led national advocacy teams on Capitol Hill and continues to advise on chronic-illness policy and data-modernization efforts.

Through CYNAERA, she develops modular AI platforms, including the IACC Progression Continuum™, Primary Chronic Trigger (PCT)™, RAVYNS™, and US-CCUC™, that are made to help governments, universities, and clinical teams model infection-associated conditions and improve precision in research and trial design. US-CCUC™ prevalence correction estimates have been used by patient advocates in congressional discussions related to IACC research funding and policy priorities. Cynthia has been featured in TIME, Bloomberg, USA Today, and other major outlets, for community engagement, policy and reflecting her ongoing commitment to advancing innovation and resilience from her home in Northern Virginia.

Cynthia’s work with complex chronic conditions is deeply informed by her lived experience surviving the first wave of the pandemic, which strengthened her dedication to reforming how chronic conditions are understood, studied, and treated. She is also an advocate for domestic-violence prevention and patient safety, bringing a trauma-informed perspective to her research and policy initiatives.

References

1. Adams, V., Kaufman, S. R., van Hattum, T., & Moody, S. (2011). Aging disaster: Mortality, vulnerability, and long-term recovery among Katrina survivors. Medical Anthropology, 30(3), 247–270. https://doi.org/10.1080/01459740.2011.560777

2. Al-Aly, Z., Bowe, B., & Xie, Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nature Medicine, 28(7), 1461–1467. https://doi.org/10.1038/s41591-022-01840-0

3. Al-Aly, Z., Xie, Y., & Bowe, B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature, 594(7862), 259–264. https://doi.org/10.1038/s41586-021-03553-9

4. Alderman, K., Turner, L. R., & Tong, S. (2012). Floods and human health: A systematic review. Environment International, 47, 37–47. https://doi.org/10.1016/j.envint.2012.06.003

5. Alderwick, H., & Gottlieb, L. M. (2019). Meanings and misunderstandings: A social determinants of health lexicon for health care systems. The Milbank Quarterly, 97(2), 407–419. https://doi.org/10.1111/1468-0009.12390

6. Aldrich, D. P., & Meyer, M. A. (2015). Social capital and community resilience. American Behavioral Scientist, 59(2), 254–269. https://doi.org/10.1177/0002764214550299

7. ATSDR (Agency for Toxic Substances and Disease Registry). (2021). Guidance for inhalation exposure (Version 5). U.S. Department of Health and Human Services.

8. Brook, R. D., Rajagopalan, S., Pope, C. A., III, Brook, J. R., Bhatnagar, A., Diez-Roux, A. V., Holguin, F., Hong, Y., Luepker, R. V., Mittleman, M. A., Peters, A., Siscovick, D., Smith, S. C., Jr., Whitsel, L., & Kaufman, J. D. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121(21), 2331–2378. https://doi.org/10.1161/CIR.0b013e3181dbece1

9. Cascio, W. E. (2018). Wildland fire smoke and human health. Science of the Total Environment, 624, 586–595. https://doi.org/10.1016/j.scitotenv.2017.12.086

10. Ciencewicki, J., & Jaspers, I. (2007). Air pollution and respiratory viral infection. Inhalation Toxicology, 19(14), 1135–1146. https://doi.org/10.1080/08958370701665434

11. Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine, 38, 101019. https://doi.org/10.1016/j.eclinm.2021.101019

12. Du, W., FitzGerald, G. J., Clark, M., & Hou, X.-Y. (2010). Health impacts of floods. Prehospital and Disaster Medicine, 25(3), 265–272. https://doi.org/10.1017/S1049023X00008141

13. EPA (U.S. Environmental Protection Agency). (2017). Protective action guides and planning guidance for radiological incidents (EPA-400/R-17/001).

14. EPA (U.S. Environmental Protection Agency). (2025). Volatile organic compounds’ impact on indoor air quality. Indoor Air Quality (IAQ) Guidance.

15. FEMA (Federal Emergency Management Agency). (2019). Radiological emergency preparedness program manual (FEMA P-1028).

16. Frumkin, H., & Haines, A. (2019). Global environmental change and noncommunicable disease risks. (Referenced in National Academies climate and health summaries and related environmental health syntheses.)

17. Gawda, A., Majka, G., Nowak, B., & Marcinek, J. (2017). Air pollution, oxidative stress, and exacerbation of autoimmune diseases. Central-European Journal of Immunology, 42(3), 305–312. https://doi.org/10.5114/ceji.2017.70975

18. Gottlieb, L. M., Hessler, D., Long, D., Amaya, A., Adler, N., & Lorig, K. (2016). Effects of social needs screening and in-person service navigation on child health: A randomized clinical trial. JAMA Pediatrics, 170(11), e162521. https://doi.org/10.1001/jamapediatrics.2016.2521

19. HHS ASPR (Assistant Secretary for Preparedness and Response). (2017). 2017–2022 health care preparedness and response capabilities.

20. Igarashi, Y., Nakajima, S., Yamaguchi, H., et al. (2018). Long-term outcomes of patients evacuated from hospitals near the Fukushima Daiichi nuclear power plant accident: A retrospective cohort study. PLOS ONE, 13(4), e0195684. https://doi.org/10.1371/journal.pone.0195684

21. Institute of Medicine. (2004). Damp indoor spaces and health. The National Academies Press.

22. Iwasaki, A., & Putrino, D. (2023). Why we need a deeper understanding of the pathophysiology of long COVID. The Lancet Infectious Diseases, 23(4), 393–395. https://doi.org/10.1016/S1473-3099(23)00053-1

23. Jerrett, M., Burnett, R. T., Pope, C. A., III, Ito, K., Thurston, G., Krewski, D., Shi, Y., Calle, E., & Thun, M. (2009). Long-term ozone exposure and mortality. The New England Journal of Medicine, 360(11), 1085–1095. https://doi.org/10.1056/NEJMoa0803894

24. Kessler, R. C., Hurricane Katrina Community Advisory Group. (2007). Hurricane Katrina’s impact on the care of survivors with chronic medical conditions. Journal of General Internal Medicine, 22(9), 1225–1230. https://doi.org/10.1007/s11606-007-0294-1

25. Kishore, N., Marqués, D., Mahmud, A., Kiang, M. V., Rodriguez, I., Fuller, A., Ebner, P., Sorensen, C., Racy, F., Lemery, J., & Balsari, S. (2018). Mortality in Puerto Rico after Hurricane Maria. The New England Journal of Medicine, 379(2), 162–170. https://doi.org/10.1056/NEJMsa1803972

26. Kimata, H. (2004). Effect of exposure to volatile organic compounds on plasma levels of neuropeptides, nerve growth factor and histamine in patients with self-reported multiple chemical sensitivity. International Journal of Hygiene and Environmental Health, 207(2), 159–163. https://doi.org/10.1078/1438-4639-00271

27. Komaroff, A. L. (2021). Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends in Molecular Medicine, 27(9), 895–906. https://doi.org/10.1016/j.molmed.2021.06.002

28. Komaroff, A. L., & Bateman, L. (2021). Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Frontiers in Medicine, 7, 606824. https://doi.org/10.3389/fmed.2020.606824

29. Komaroff, A. L., & Lipkin, W. I. (2023). ME/CFS and long COVID share similar symptoms and biological abnormalities: Road map to the literature. Frontiers in Medicine, 10, 1187163. https://doi.org/10.3389/fmed.2023.1187163

30. Lipkin, W. I. (Referenced). For environmental sensitivity claims in this draft, the most consistently citable public-health anchors are CDC and ATSDR environmental health guidance rather than a single Lipkin-led environmental trigger report.

31. Mendell, M. J., Mirer, A. G., Cheung, K., Tong, M., & Douwes, J. (2011). Respiratory and allergic health effects of dampness, mold, and dampness-related agents: A review of the epidemiologic evidence. Environmental Health Perspectives, 119(6), 748–756. https://doi.org/10.1289/ehp.1002410

32. National Academies of Sciences, Engineering, and Medicine. (2024). A long COVID definition: A chronic, systemic disease state with profound consequences. The National Academies Press. https://doi.org/10.17226/27768

33. Naviaux, R. K., Naviaux, J. C., Li, K., Bright, A. T., Alaynick, W. A., Wang, L., Baxter, A., Nathan, N., Anderson, W., & Gordon, E. (2016). Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 113(37), E5472–E5480. https://doi.org/10.1073/pnas.1607571113

34. Nomura, S., Gilmour, S., Tsubokura, M., Yoneoka, D., Sugimoto, A., Oikawa, T., Kami, M., & Shibuya, K. (2013). Mortality risk amongst nursing home residents evacuated after the Fukushima nuclear accident: A retrospective cohort study. PLOS ONE, 8(3), e60192. https://doi.org/10.1371/journal.pone.0060192

35. Nomura, S., Blangiardo, M., Tsubokura, M., Nishikawa, Y., Gilmour, S., & Kami, M. (2016). Post-nuclear disaster evacuation and survival amongst elderly residents in long-term care facilities: A comparative analysis. Social Science & Medicine, 164, 166–173. https://doi.org/10.1016/j.socscimed.2016.07.026

36. NRC (U.S. Nuclear Regulatory Commission). (2026). Regulations, guidance, and generic communications for emergency preparedness. NRC Emergency Preparedness Guidance Portal.

37. Ogbodo, J. O., Asemahagn, M. A., & others. (2022). Volatile organic compounds: A proinflammatory activator in autoimmune diseases. Frontiers in Immunology, 13, 922641. https://doi.org/10.3389/fimmu.2022.922641

38. Peluso, M. J., Deeks, S. G., & Henrich, T. J. (2024). Mechanisms of long COVID and the path toward therapeutics. Cell, 187(16), 4026–4043. https://doi.org/10.1016/j.cell.2024.08.016

39. Peek, L., Abramson, D. M., Cox, R. S., Fothergill, A., & Tobin, J. (2018). Children and disasters. In H. Rodríguez, W. Donner, & J. E. Trainor (Eds.), Handbook of disaster research (2nd ed.). Springer.

40. Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., & Kelleher, A. D. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology, 23(2), 210–216. https://doi.org/10.1038/s41590-021-01113-x

41. Pope, C. A., III, & Dockery, D. W. (2006). Health effects of fine particulate air pollution: Lines that connect. Journal of the Air & Waste Management Association, 56(6), 709–742. https://doi.org/10.1080/10473289.2006.10464485

42. Raj, S. R., Guzman, J. C., Harvey, P., Richer, L., Schondorf, R., Seifer, C., Thibodeau-Jarry, N., & Sheldon, R. S. (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ, 194(10), E378–E385. https://doi.org/10.1503/cmaj.211373

43. Reid, C. E., Brauer, M., Johnston, F. H., Jerrett, M., Balmes, J. R., & Elliott, C. T. (2016). Critical review of health impacts of wildfire smoke exposure. Environmental Health Perspectives, 124(9), 1334–1343. https://doi.org/10.1289/ehp.1409277

44. Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., Molteni, E., Modat, M., Jorge Cardoso, M., May, A., Ganesh, S., Davies, R., Nguyen, L. H., Drew, D. A., Astley, C. M., … Steves, C. J. (2021). Attributes and predictors of long COVID. Nature Medicine, 27(4), 626–631. https://doi.org/10.1038/s41591-021-01292-y

45. Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q., Harrison, P. J. (2022). Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1,284,437 patients. The Lancet Psychiatry, 9(10), 815–827. https://doi.org/10.1016/S2215-0366(22)00260-7

46. Vernino, S., Bourne, K. M., Stiles, L. E., Grubb, B. P., Fedorowski, A., Stewart, J. M., Arnold, A. C., Pace, L. A., Axelrod, F. B., Boris, J. R., Chelimsky, T. C., Claydon, V. E., Garland, E. M., Gibbons, C. H., Okamoto, L. E., Raj, S. R., Sheldon, R. S., Singer, W., & Benarroch, E. E. (2021). Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care. Autonomic Neuroscience, 235, 102828. https://doi.org/10.1016/j.autneu.2021.102828

47.